Breast Oncology Flashcards
what oncological treatments exist
radiotherapy
chemotherapy
hormonal therapy (oestrogen blockade)
antibodies (e.g. trastuzumab (herceptin))
what are the treatment options for a curative cancer
neo-adjuvant
adjuvant
radical (treating cancer with oncological tx alone)
what is the role of adjuvant therapy
acts as back up to oncological Tx, wont cure it on its own but improves survival
what neoadjuvant therapies are given for breast cancer
hormonal therapy- for ER +ve tumours (can be given up to a year before surgery)
chemotherapy- can allow WLE instead of mastectomy
what is the disadvantage of neo aduvant chemo
need to attend for 6 extra imaging investigations compared with adjuvant therapy
what adjuvant therapies are used in breast cancer
radiotherapy (used after WLE)
ER blockade (5 years of tamoxifen or aromatase inhibitors (letrozole, anastrozole)
chemotherapy (usually anthracycline and taxane)
trastuzumab (herceptin - antibody against HER2)
how is adjuvant radiotherapy given
external beam therapy using linac over 3 weeks
extra boost sometimes makes tx longer- indicated if young age or positive margins
whar are the SEs of ER blockade
tamoxifen- DVT, PE, (is a partial agonist, paritally oestrogenic=will cause endometrium to proliferate) bleeding, polyps, endometrial cancer, endometrial hyperplasia
(may need to switch to goserelin)
AIs- heart problems, osteoporosis
why are AIs given to postmenopausal women
cant stop ovaries making oestrogen so given to post menopausal
are more effective in post menopausal
cause less clots and endometrial cancer
what are the side effects of chemotherapy
anorexia malaise neutropenia alopecia myalgia peripheral neuropathy gCSF infections- these can cause severe axial skeletal pain from marrow stimulation
how is trastuzumab given
sc injection
one year of 3 weekly treatments
only for cancers that overexpress HER2
what are the risks of trastuzumab
allergic reactions
reversible cardiac failure
what happens at the end of adjuvant treatment
review at end
discharge
surgical review on anniversary of surgery
yearly mammograms for 3 years
what are the palliative options for breast cancer
systemic Tx for widespread disease- ER blockage or chemotherapy
radiotherapy for fungating breast disease/ bone mets
bisphosphonates for bone mets to prevent risk of #
how is radiotherapy delivered
cancer localised
beams targeted to area, avoiding heart (exposure increases risk of ischaemic heart disease)
proton or electron (better for more superficial lesions)